ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 237,52
0,33%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. CASI Pharmaceuticals Inc (CASI) Cours

CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc (CASI)

NASDAQ
2,225
0,155
(7,49%)
Fermé 15 Mars 9:00PM
Retardé de 15 minutes
2,225
0,00
(0,00%)
Après les heures de négociation: 9:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
2,225
Prix Achat
2,08
Prix Vente
2,54
Volume échangé
7 553
2,04 Fourchette du Jour 2,40
2,0415 Plage de 52 semaines 7,67
Cap du marché
34,4M
Clôture Veille
2,07
Ouverture
2,04
Dernière Transaction
9
@
2.18
Dernière heure de transaction
Volume financier
US$ 16 877
VWAP
2,2345
Volume moyen (3 m)
22 818
Actions en circulation
15 460 457
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,27
Bénéfice par action (BPA)
-1,74
Chiffre d'affairess
40,25M
Bénéfice net
-26,96M

À propos de CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before a... CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.casipharmaceuticals.com
Siège social
Grand Cayman, Cym
Fondé
-
CASI Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker CASI. Le dernier cours de clôture d'CASI Pharmaceuticals était de US$2,07. Au cours de la dernière année, les actions de CASI Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 2,0415 à US$ 7,67.

CASI Pharmaceuticals compte actuellement 15 460 457 actions en circulation. La capitalisation boursière d'CASI Pharmaceuticals est de US$32,00 million. CASI Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -1.27.

CASI Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
10 Février 2025
CASI (7,49%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
21 Janvier 2025
CASI (7,49%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
02 Janvier 2025
CASI (7,49%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
26 Décembre 2024
CASI (7,49%)

Form F-3/A - Registration statement by foreign private issuers: [Amend]
Edgar (US Regulatory)
23 Décembre 2024
CASI (7,49%)

Form F-3 - Registration statement by foreign private issuers
Edgar (US Regulatory)
20 Décembre 2024
CASI (7,49%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
16 Décembre 2024
CASI (7,49%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
15 Novembre 2024
CASI (7,49%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
12 Septembre 2024
CASI (7,49%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.195-8.057851239672.422.422.041533392.16776746CS
4-0.376-14.45597846982.6012.652.041569952.36723597CS
12-0.465-17.28624535322.693.472.0415228182.71229516CS
26-4.935-68.92458100567.167.52.0415303174.17113013CS
52-1.575-41.44736842113.87.672.0415900264.53059326CS
156-6.375-74.12790697678.610.31.451164494.67804486CS
260-13.275-85.645161290315.5391.4546658414.38552797CS

CASI - Frequently Asked Questions (FAQ)

What is the current CASI Pharmaceuticals share price?
The current share price of CASI Pharmaceuticals is US$ 2,225
How many CASI Pharmaceuticals shares are in issue?
CASI Pharmaceuticals has 15 460 457 shares in issue
What is the market cap of CASI Pharmaceuticals?
The market capitalisation of CASI Pharmaceuticals is USD 32M
What is the 1 year trading range for CASI Pharmaceuticals share price?
CASI Pharmaceuticals has traded in the range of US$ 2,0415 to US$ 7,67 during the past year
What is the PE ratio of CASI Pharmaceuticals?
The price to earnings ratio of CASI Pharmaceuticals is -1,27
What is the cash to sales ratio of CASI Pharmaceuticals?
The cash to sales ratio of CASI Pharmaceuticals is 0,85
What is the reporting currency for CASI Pharmaceuticals?
CASI Pharmaceuticals reports financial results in USD
What is the latest annual turnover for CASI Pharmaceuticals?
The latest annual turnover of CASI Pharmaceuticals is USD 40,25M
What is the latest annual profit for CASI Pharmaceuticals?
The latest annual profit of CASI Pharmaceuticals is USD -26,96M
What is the registered address of CASI Pharmaceuticals?
The registered address for CASI Pharmaceuticals is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104
What is the CASI Pharmaceuticals website address?
The website address for CASI Pharmaceuticals is www.casipharmaceuticals.com
Which industry sector does CASI Pharmaceuticals operate in?
CASI Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CASI
CASI Pharmaceuticals
ASX
BYE
Byron Energy
ASX
FAL
Falcon Metals
ASX
BIR
BIR Financial
NYSE
LRT
L L E Royal TR Ubi
LSE
HMCA
China A
FX
EUECBINT
ECB Interest Rate
BIT
P1JS35
BNP Paribas Issuance
TG
JREM
JPMorgan ETF
NASDAQ
PTCT
PTC Therapeutics
LSE
0I0B
Clearsign Combustion
ASX
BYHOA
Bryah Resources
LSE
ELEG
Electric Guitar
TG
F1X2
Finland
BIT
LTAM
Exchange Traded Funds
LSE
0NWC
Secunet Security Networks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces